Curated News
By: NewsRamp Editorial Staff
October 31, 2025
39 Attorneys General Demand Congress Ban Hemp THC Products
TLDR
- Cannabis companies like Canopy Growth Corp could gain market advantage if Congress bans hemp-derived THC products, reducing competition from synthetic alternatives.
- Thirty-nine attorneys general are requesting Congress revise the 2018 Farm Bill to close a loophole allowing nationwide sale of hemp-derived psychoactive THC products.
- Closing the hemp THC loophole would protect public health by restricting access to unregulated psychoactive substances and ensuring safer consumer products.
- Thirty-seven states and two territories united to challenge federal hemp laws, creating a pivotal moment in cannabis regulation history with widespread industry implications.
Impact - Why it Matters
This regulatory push could fundamentally reshape the legal cannabis market, affecting everything from consumer access to hemp-derived products to the business models of major cannabis companies. For consumers, it might mean restricted availability of certain THC products currently sold as legal hemp derivatives. For investors and businesses in the cannabis space, this represents significant regulatory risk that could impact company valuations and market strategies. The outcome could set important precedents for how psychoactive cannabis products are regulated at the federal level, potentially influencing future legislation around marijuana legalization and creating new compliance challenges across the industry.
Summary
A coalition of 39 attorneys general from 37 U.S. states and two territories has launched a significant push for federal action against hemp-derived THC products, marking one of the most substantial regulatory challenges facing the cannabis industry. These top legal officials sent a formal letter on October 24 to key Senate and House committee leaders, demanding immediate congressional intervention to close what they describe as a dangerous loophole in the 2018 Farm Bill. The attorneys general argue that this legislative gap has allowed synthetic, psychoactive products to proliferate nationwide, creating what they characterize as a public health crisis that requires urgent federal attention.
The regulatory crackdown being advocated by these attorneys general could have profound implications for major cannabis companies, including international players like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), which will be closely monitoring whether Congress takes up the proposed restrictions. The coalition's unified stance represents a significant escalation in the ongoing debate about hemp regulation, potentially setting the stage for major legislative changes that could reshape the entire cannabis market landscape. This development comes at a critical juncture for the industry, as stakeholders across the sector await potential congressional action that could dramatically alter the legal framework governing hemp-derived products.
This breaking news was reported by CNW420, which provides daily cannabis industry updates at 4:20 p.m. Eastern Time, serving investors and industry professionals who need to stay informed about regulatory developments that could impact financial markets. The platform's coverage highlights how this coordinated action by attorneys general represents a pivotal moment in the ongoing evolution of cannabis regulation, with potential consequences for businesses, consumers, and investors alike as the industry navigates increasingly complex legal terrain.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, 39 Attorneys General Demand Congress Ban Hemp THC Products
